Lifestyle Drugs Global Strategic Business Report 2024

Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Lifestyle Drugs - Global Strategic Business Report" report has been added to's offering.

Global Lifestyle Drugs Market to Reach $46 Billion by 2030

The global market for Lifestyle Drugs estimated at US$37.3 Billion in the year 2023, is projected to reach a revised size of US$46 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030.

Lifestyle Drugs for Obesity, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$19.5 Billion by the end of the analysis period. Growth in the Lifestyle Drugs for Dermatology segment is estimated at 2.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $11.2 Billion, While China is Forecast to Grow at 2.9% CAGR

The Lifestyle Drugs market in the U.S. is estimated at US$11.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$8.2 Billion by the year 2030 trailing a CAGR of 2.9% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 2.5% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Key Attributes:

Report AttributeDetails
No. of Pages184
Forecast Period2023 - 2030
Estimated Market Value (USD) in 2023$37.3 Billion
Forecasted Market Value (USD) by 2030$46 Billion
Compound Annual Growth Rate3.1%
Regions CoveredGlobal

Key Topics Covered:




  • Influencer Market Insights
  • World Market Trajectories
  • Lifestyle Drugs - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Economic Update
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)


  • Alembic Pharmaceuticals Limited
  • Amgen, Inc.
  • AstraZeneca PLC
  • Biocon Ltd.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Lupin Ltd.
  • Merck & Co., Inc.
  • Mylan Pharmaceuticals, Inc.
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Piramal Enterprises Limited
  • Procter & Gamble Company, The
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Cadila

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Lifestyle Drugs Market

Contact Data